Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement

International Angiology

Volumn 25, Issue 1, 2006, Pages 60-66

  Yale, Steven H ^a   Mazza, J J ^a   Glurich, I ^a   Peters, T ^a   Mukesh, B N ^b  

^a MARSHFIELD CLINIC   (United States)

^b Mashfield Clinic Research Foundation   (United States)

Author keywords

Anticoagulation; Thromboembolism; Vena caval filter; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGE; AGED; ANTICOAGULATION; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HUMAN; INFERIOR CAVA VEIN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SMOKING; SURVIVAL; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME; VENA CAVA FILTERS; VENOUS THROMBOSIS; WARFARIN;

EID: 33645820641     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Guyatt G, Schunëmann H, Cook D, Jaeschke R, Pauker S, Bucher H; American College of Chest Physicians. Grades of recommendation for antithrombotic agents. Chest 2001; 119 Suppl 1:3S-7.
2. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119 Suppl 1: 176S-93.
3. Norris CS, Greenfield LJ, Herrmann JB. Free-floating iliofemoral thrombus. A risk of pulmonary embolism. Arch Surg 1985; 120:806-8.
4. Girard P, Stern JB, Parent F. Medical literature and vena cava filters: so far so weak. Chest 2002;122:963-7.
5. Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000;216:54-66.
6. Cohen JR, Tenenbaum N, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery 1991;109:12-5.
7. Calligaro KD, Bergen WS, Haut MJ, Savarese RP, DeLaurentis DA. Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement. Ann Vasc Surg 1991;5:186-9.
8. Cohen JR, Grella L, Citron M. Greenfield filter instead of heparin as primary treatment of deep venous thrombosis or pulmonary embolism in patients with cancer. Cancer 1992;70:1993-6.
9. Schwarz RE, Marrero AM, Conlon KC, Burt M. Inferior vena cava filters in cancer patients: indications and outcome. J Clin Oncol 1996;14:652-7.
10. Moore FD Jr, Osteen RT, Karp DD, Steele G Jr, Wilson RE. Anticoagulants, venous thromboembolism, and the cancer patient. Arch Surg t981;1 16:405-7.
11. Proctor MC. Indications for filter placement. Semin Vasc Surg 2000;13:194-8.
12. Mohan CR, Hoballah JJ, Sharp WJ, Kresowik TF, Lu CT, Corson JD. Comparative efficacy and complications of vena caval filters. J Vasc Surg 1995;21:235-45.
13. Simon M, Athanasoulis CA, Kim D, Steinberg FL, Porter DH, Byse BH et al. Simon Nitinol inferior vena cava filter: initial clinical experience. Work in progress. Radiology 1989;172:99-103.
14. Roehm JO Jr. Johnsrude IS, Barth MH, Gianturco C. The bird's nest inferior vena cava filter: progress report. Radiology 1988;168:745-9.
15. Epstein DH, Darcy MD, Hunter DW, Coleman CC, Tadavarthy SM, Murray PD et al. Experience with the Amplatz retrievable vena cava filter. Radiology 989;172:105-10.
16. Millward SF, Marsh JI, Peterson RA, Rasuli P, French G, Wilson CM et al. LGM (Vena Tech) vena cava filter: clinical experience in 64 patients. J Vasc Interv Radiol 1991;2:429-33.
17. Crochet DP, Stora O, Ferry D, Grossetete R, Leurent B, Brunel P et al. Vena Tech-LGM filter: long-term results of a prospective study Radiology 1993;188:857-60.
18. Ferris EJ, McCowan TC, Carver DK, McFarland DR. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients. Radiology 1993;188:851-6.
19. Greenfield LJ, Michna BA. Twelve-year clinical experience with the Greenfield vena caval filter. Surgery 1988;104:706-12.
20. Greenfield LJ, Proctor MC. Thromboembolism: prevention and treatment with vena cava filters. Semin Arthroplasty 1992;3:123-7.
21. Greenfield LJ, Proctor MC, Cho KJ, Cutler BS, Ferris EJ, McFarland D et al. Extended evaluation of the titanium Greenfield vena caval filter. J Vasc Surg 1994;20:458-64.
22. Wojtowycz MM, Stoehr T, Crummy AB, McDermott JC, Sproat IA. The Bird's Nest inferior vena caval filter: review of a single-center experience. J Vasc Interv Radiol 1997;8:171-9.
23. Lord RS, Berm I. Early and late results after Bird's Nest filter placement in the inferior vena cava: clinical and duplex ultrasound follow up.Aust N Z J Surg 1994;64:106-14.
24. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998;338:409-15.
25. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-34.
26. Fink JA, Jones BT. The Greenfield filter as the primary means of therapy in venous thromboembolic disease. Surg Gynecol Obstet 1991;172:253-6.
27. Nicholson AA, Ettles DF, Paddon AJ, Dyet JE Long-term follow-up of the Bird's Nest IVC Filter. Clin Radiol 1999;54:759-64.
28. Schleich JM, Morla O, Laurent M, Langella B, Chaperon J, Almange C. Long-term follow-up of percutaneous vena cava filters: a prospective study in 100 consecutive patients. Eur J Vasc Endovasc Surg 2001;21:450-7.
29. Ortega M, Gahtan V, Roberts A, Matsumoto T, Kerstein M. Efficacy of anticoagulation postinferior vena caval filter placement. Am Surg 1998;64:419-23.
30. Greenfield LJ, Proctor MC. Twenty-year clinical experience with the Greenfield filter. Cardiovasc Surg 1995;3:199-205.
31. Greenfield LJ, Proctor MC. The percutaneous Greenfield filter: outcomes and practice patterns. J Vasc Surg 2000;32:888-93.
32. Greenfield LJ, Proctor MC. Recurrent thromboembolism in patients with vena cava filters. J Vasc Surg 2001;33: 510-4.
33. Jones B, Fink JA, Donovan DL, Sharp WV. Analysis of benefit of anticoagulation after placement of Kimray-Greenfield filter. Surg Gynecol Obstet 1989; 169:400-2.
34. Kolachalam RB, Julian TB. Clinical presentation of thrombosed Greenfield filters. Vasc Surg 1990;24:666-70.
35. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
36. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995;332:1661-5.
37. Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 1997;336:393-8.
38. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-34.
39. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003;349:631-9.
40. Greenfield LJ, Cho KJ, Proctor M, Bonn J, Bookstein JJ, Castaneda-Zuniga WR et al. Results of a multicenter study of the modified hook-titanium Greenfield filter. J Vasc Surg 1991;14:253-7.
41. Dorfman GS, Cronan JJ, Paolella LP, Lambiase RE, Haas RA, Scola FH et al. Iatrogenic changes at the venotomy site after percutaneous placement of the Greenfield filter. Radiology 1989;173:159-62.
42. Pais SO, Tobin KD, Austin CB, Queral L. Percutaneous insertion of the Greenfield inferior vena cava filter: experience with ninety-six patients. J Vasc Surg 1988;8: 460-4.
43. Kantor A, Glanz S, Gordon DH, Sclafani SJ. Percutaneous insertion of the Kimray-Greenfield filter: incidence of femoral vein thrombosis. AJR Am J Roentgenol 1987;149:1065-6.
44. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 1992;152:1985-94.
45. Mewissen MW, Erickson SJ, Foley WD, Lipchik EO, Olson DL, McCann KM et al. Thrombosis at venous insertion sites after inferior vena caval filter placement. Radiology 1989;173:155-7.
46. Greenfield LJ, Cho KJ, Tauscher JR. Limitation of percutaneous insertion of Greenfield filters. J Cardiovasc Surg 1990;31:344-50.
47. Dorfman GS. Percutaneous inferior vena caval filters. Radiology 1990;174:987-92.